IMPower133 study
The IMpower133 study has brought significant advancements in the treatment of advanced-stage small-cell lung cancer (ES-SCLC). By combining atezolizumab, a type of immunotherapy, wit...
cancer-treatment
On May 14, 2025, the Food and Drug Administration sanctioned belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients aged 12 and older diagnosed with locally advanced, unresectabl...
cancer-treatment
Introduction
Abdominal radiotherapy is a type of cancer treatment that uses high-energy radiation to destroy cancer cells in the abdominal region. It is commonly used to treat cancers affec...
cancer-treatment
Bile Duct Cancer Treatment
Bile duct cancer, also known as cholangiocarcinoma, is a rare but aggressive cancer that develops in the bile ducts—the tubes that carry bile from the liver to th...
cancer-treatment
Cancer Treatment
Cancer is a leading cause of death worldwide, but advancements in medical science have significantly improved treatment options. From surgery to immunotherapy, patients now h...
cancer-treatment
Salivary Gland Cancer Treatment
Salivary gland cancer is an uncommon malignancy that arises in the salivary glands, responsible for producing saliva for digestion and oral wellness. Although rare, ea...
cancer-treatment
Small Intestine Cancer Treatment
Small intestine cancer is a rare yet severe disorder of the gastrointestinal tract. While it is responsible for fewer than 1% of all gastrointestinal cancers, early t...
cancer-treatment